Related references
Note: Only part of the references are listed.Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Shunsuke Kondo et al.
BMC CANCER (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
Bin Bao et al.
CANCER RESEARCH (2012)
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
Hee Yi et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2012)
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Julie Mathieu et al.
CANCER RESEARCH (2011)
Identification of MicroRNAs Involved in Hypoxia- and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem Cells
Yu Nie et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
被撤回的出版物: Down-Regulation of Notch-1 Is Associated With Akt and FoxM1 in Inducing Cell Growth Inhibition and Apoptosis in Prostate Cancer Cells (Retracted article. See vol. 117, pg. 1962, 2016)
Zhiwei Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Bioactive compounds from natural resources against skin aging
Pulok K. Mukherjee et al.
PHYTOMEDICINE (2011)
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
Bin Bao et al.
PLOS ONE (2011)
MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression
Ling-Zhi Liu et al.
PLOS ONE (2011)
Invited review: decoding the microRNA response to hypoxia
Roger Pocock
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2011)
MicroRNAs and prostate cancer
Yingxin Pang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials
Adeeb Shehzad et al.
ARCHIV DER PHARMAZIE (2010)
Anthropometric Measures, Body Mass Index, and Pancreatic Cancer A Pooled Analysis From the Pancreatic Cancer Cohort Consortium (PanScan)
Alan A. Arslan et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
The ubiquitous interleukin-6: a time for reappraisal
Enrique Z. Fisman et al.
CARDIOVASCULAR DIABETOLOGY (2010)
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
Shijun Hu et al.
CIRCULATION (2010)
Lesson Learned from Nature for the Development of Novel Anti-Cancer Agents: Implication of Isoflavone, Curcumin, and their Synthetic Analogs
Fazlul H. Sarkar et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
Maria-del-Mar Inda et al.
GENES & DEVELOPMENT (2010)
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
Thomas Greither et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Adrian M. Jubb et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1 alpha Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
Carol L. Nilsson et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Perspectives on Chemopreventive and Therapeutic Potential of Curcumin Analogs in Medicinal Chemistry
S. Padhye et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
Paul Cao et al.
MOLECULAR CANCER (2010)
MiR-210-micromanager of the hypoxia pathway
Xin Huang et al.
TRENDS IN MOLECULAR MEDICINE (2010)
MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications
Jeffrey T. DeSano et al.
AAPS JOURNAL (2009)
Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics
Fazlul H. Sarkar et al.
CANCER TREATMENT REVIEWS (2009)
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
Taiki Moriyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
miR-200 Regulates PDGF-D-Mediated Epithelial-Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells
Dejuan Kong et al.
STEM CELLS (2009)
Mammalian target of rapamycin repression by 3,3′-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells
Dejuan Kong et al.
CANCER RESEARCH (2008)
A microRNA component of the hypoxic response
R. Kulshreshtha et al.
CELL DEATH AND DIFFERENTIATION (2008)
Curcumin: From ancient medicine to current clinical trials
H. Hatcher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
Mary Dillhoff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Synergistic effects of multiple natural products in pancreatic cancer cells
Zhiwei Wang et al.
LIFE SCIENCES (2008)
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Vera Levina et al.
PLOS ONE (2008)
A microRNA signature of hypoxia
Ritu Kulshreshtha et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
MicroRNAs in the search for understanding human diseases
Ranjan F. Perera et al.
BIODRUGS (2007)
MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia
Zhong Hua et al.
PLOS ONE (2006)
Interleukin-6 and its receptor: from bench to bedside
Juergen Scheller et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2006)
Hypoxia requires Notch signaling to maintain the undifferentiated cell state
MV Gustafsson et al.
DEVELOPMENTAL CELL (2005)
Annual report to the Nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
BK Edwards et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Share Paper
